<code id='2730C20257'></code><style id='2730C20257'></style>
    • <acronym id='2730C20257'></acronym>
      <center id='2730C20257'><center id='2730C20257'><tfoot id='2730C20257'></tfoot></center><abbr id='2730C20257'><dir id='2730C20257'><tfoot id='2730C20257'></tfoot><noframes id='2730C20257'>

    • <optgroup id='2730C20257'><strike id='2730C20257'><sup id='2730C20257'></sup></strike><code id='2730C20257'></code></optgroup>
        1. <b id='2730C20257'><label id='2730C20257'><select id='2730C20257'><dt id='2730C20257'><span id='2730C20257'></span></dt></select></label></b><u id='2730C20257'></u>
          <i id='2730C20257'><strike id='2730C20257'><tt id='2730C20257'><pre id='2730C20257'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:77

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          The FDA must approve intranasal treatments for anaphylaxis
          The FDA must approve intranasal treatments for anaphylaxis

          AdobeMysonThomashascarriedaroundaneedlesinceheenteredkindergartenattheageof5.Thatwasabigresponsibili

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

          BristolCEOChristopherBoernerBusinessWireviaAPSANFRANCISCO— ChristopherBoernerhasbeentheCEOofBristolM